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Abstract
Amphibole asbestos exposure is associated with production of mesothelial cell autoantibodies 
(MCAA). These MCAA have been linked with pleural fibrotic disease in the asbestos exposed 
community of Libby, Montana, and induce collagen deposition by cultured mesothelial cells. 
However, the exact intracellular mechanism by which these autoantibodies cause an increase in 
collagen deposition remains unknown. This study sought to gain insight into the transcription 
factors involved in the collagen production after human mesothelial cells are exposed to MCAA. 
In this study, transcription factor activation profiles were generated from human mesothelial cells 
(Met5A) treated with serum from Libby subjects, and were compared to cells treated with serum 
cleared of IgG, and therefore containing no MCAA. Analysis of those profiles indicated C/EBP-
beta and hypoxia inducible factor 1 alpha (HIF-1α) are significantly increased in the nucleus, 
indicating activation, due to MCAA exposure compared to controls. Inhibition of either of these 
transcription factors significantly reduced collagen 1 deposition by these cells following exposure 
to MCAA. These data suggest autoantibodies are directly involved in type I collagen deposition 
and may elucidate potential therapeutic targets for autoantibody mediated fibrosis.
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Introduction
A mine near Libby, Montana, USA, was the largest producer of vermiculite in the world 
from the early 1920s to 1990 (Meeker et al. 2003). Vermiculite is a mineral well known for 
its ability to resist changes in temperature and degradation, making this silicate mineral 
desirable for use in many products. Unfortunately, the vermiculite ore bed was contaminated 
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with a unique type of amphibole asbestos now referred to as Libby Amphibole (LA) (Black 
et al. 2014). Many public structures in Libby were conditioned with this mineral, including 
homes, playgrounds, and the track and baseball field. Moreover, children would sometimes 
play in the piles of vermiculite, and families would use it in their gardens (Black et al. 2014). 
In 2002, the mine and the surrounding community were designated as a Superfund site by 
the U.S. Environmental Protection Agency (EPA) because of considerable health 
complications associated with LA exposure, now known to include reduced pulmonary 
function, enhanced autoimmune responses, pleural and interstitial fibrosis, and substantially 
increased mortality from lung cancer and malignant mesothelioma (Antao et al. 2012, 
Peipins et al. 2003, Pfau et al. 2005, Whitehouse et al. 2008). Vermiculite containing 0.3–
7.0% LA was shipped to processing plants spread throughout the United States as well as 
other countries (Sullivan 2007), and millions of homes and other buildings still contain the 
material.
Asbestos-Related Diseases (ARD) noted in the Libby population include both malignant 
(mesothelioma) and non-malignant pleural disease, in addition to classical pulmonary 
fibrosis, termed asbestosis (Larson et al. 2010, Winters et al. 2012). Pleural disease, 
however, is the most prevalent pulmonary outcome in Libby, causing significant morbidity 
and mortality (Peipins et al. 2003), with an atypical clinical presentation including severe 
chest pain and rapid progression (Black et al. 2014). Moreover, an increase in the risk for 
systemic autoimmune diseases, specifically Systemic Lupus Erythematosus (SLE), 
Rheumatoid Arthritis (RA), and Systemic Sclerosis (SSc), has also been reported (Noonan et 
al. 2006, Pfau et al. 2014). An increased frequency of positive antinuclear autoantibody 
(ANA) tests occurs in this population and others exposed to amphibole asbestos (Marchand 
et al. 2012, Pfau et al. 2005, Pfau et al. 2014). Further examination of potential health effects 
of the Libby Amphibole revealed that it could induce autoantibodies in both mice and rats 
(Pfau et al. 2008, Salazar et al. 2012), while chrysotile asbestos did not (Ferro et al. 2013). 
Those data strongly support the ability of LA to induce autoimmune responses in exposed 
individuals, and there was some evidence that this immune dysfunction was associated with 
the incidence of pulmonary disease (Marchand et al. 2012, Pfau et al. 2005). Studies were 
undertaken to understand mechanisms whereby autoantibodies could play a role in the 
predominant non-malignant pulmonary diseases in Libby. This led to the discovery of tissue-
specific autoantibodies in addition to the ANA, including anti-fibroblast antibodies (AFA) in 
LA-exposed mice (Pfau et al. 2011) and mesothelial cell autoantibodies (MCAA) in a LA-
exposed cohort (Marchand et al. 2012). These autoantibodies subsequently were shown to 
induce collagen production in cultured fibroblasts and mesothelial cells, respectively (Pfau 
et al. 2011, Serve et al. 2013). We recently demonstrated that the LA-induced autoantibodies 
alone, in the absence of asbestos, could contribute to the fibrotic process in mice (Gilmer et 
al. 2016). The public health significance of this result is further highlighted by evidence that 
the LA non-malignant pleural disease is more severe and progressive than what is classically 
described for general occupational (chrysotile) asbestos exposures, and that the radiographic 
lesions were clearly associated with pulmonary function decline (Black et al. 2014, Larson 
et al. 2012, Whitehouse 2004).
The traditional mechanism of fibrogenesis has been well characterized, primarily focused on 
the pathways regulating production and remodeling of Type 1 collagen, one of the most 
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prevalent proteins in the extracellular matrix, ECM (Bosman and Stamenkovic 2003). 
Growth factors such as platelet derived growth factor (PDGF), fibroblast growth factor 2 
(FGF-2), and transforming growth factor beta 1(TGF-B1) are known to stimulate ECM 
deposition (Chaudhary et al. 2007). There are several transcription factors that play a role in 
the regulation of fibrosis including Smads, Sp1, and C/EBP-beta (Ghosh 2002).
However, the molecular mechanism of how mesothelial cell autoantibodies affect fibrosis 
has not been characterized, although we have shown that, in vitro, MCAA trigger collagen 
matrix deposition in the absence of epithelial-mesenchymal transition or TGF-beta signaling 
(Serve et al. 2013). Therefore, autoantibody-driven fibrosis may occur via a novel pathway, 
which could elucidate new potential targets for treatments of fibrotic diseases. We 
hypothesized that MCAA exposure leads to activation of a distinct set of transcription 
factors, and that this activation leads to collagen deposition in vitro. Based on transcription 
factor array data from mesothelial cells treated with MCAA, we predicted that transcription 
factors C/EBP-beta and hypoxia inducible factor (HIF-1α) would be activated by MCAA 
and that those activated transcription factors would result in an mRNA-expression profile 
unique to fibrosis. We further predicted that by inhibiting the transcription factors affected 
by MCAA exposure, collagen deposition stimulated by MCAA in vitro would return to 
normal levels, thereby establishing key steps in the MCAA-driven fibrotic pathway.
Materials and Methods
Human serum samples and IgG clearance
Serum samples were collected by the Center for Asbestos Related Disease (CARD) in 
Libby, Montana, USA in accordance with standard clinical protocols and the CARD clinic's 
IRB approval, then shipped to Idaho State University under IRB project approval 
#3292MOD and stored at −80°C until needed. Samples previously identified as MCAA 
positive were pooled (Serve et al. 2013) in order to provide enough serum for all 
experiments, and small aliquots were stored at −20°C. MCAA-positive serum cleared of IgG 
antibodies was used as a negative control treatment. Serum was cleared using Protein G 
Agarose Beads (Thermo Scientific, Rockford, IL) according to manufacturer’s instructions. 
Removal of detectable IgG was confirmed by SDS-PAGE, using a 12% Bis–Tris gel (Novex, 
Life Technologies, Carlsbad, CA), staining with GelCode Blue Stain Reagent (Thermo 
Scientific), and checking for lack of bands corresponding to the molecular weight of IgG 
heavy and light chains (50 and 25 kDa respectively). The IgG-cleared serum was 
subsequently shown to be MCAA-negative by cell binding ELISA, described below.
MCAA cell binding assay
A cell-based ELISA was performed as previously described (Serve et al. 2013) to confirm 
the presence of MCAA in serum samples. MeT-5A cells (ATCC, Manassas, VA) were 
seeded at confluency on 96 well plates, attached overnight and fixed in 1% 
paraformaldehyde. Following washes with phosphate-buffered saline (PBS)-Tween (0.05%), 
cells were blocked with 5% non-fat dried milk/PBS and then triplicate wells were exposed to 
either pooled MCAA-positive (MCAA+) serum samples or pooled MCAA+ serum samples 
cleared of IgG (Cleared), each diluted in 3% bovine serum albumin (BSA)/PBS (1:100). 
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Following a 2-h incubation with serum as the primary antibody, cells were washed and 
blocked a second time. The secondary antibody HRP-conjugated goat anti-human IgG 
(Jackson ImmunoResearch, West Grove, PA) was applied at a dilution of 1:1000 in 3% 
BSA/PBS and incubated for 1 h. Excess antibody was removed and plates developed using 
TMB substrate reagent (Thermo Scientific), and stopped by 30 µL/ well of 1M HCl. Plates 
were analyzed at 450 nm on a microtiter plate reader (BioTek Instruments, Winooski, VT). 
Non-specific secondary antibody binding was corrected for on a plate-to-plate basis by 
subtracting the mean optical density (OD) for the secondary antibody-only control wells 
from the mean OD of each sample.
Transcription factor profile
Human mesothelial MeT-5A cells were seeded to confluency in two wells of a six well plate 
and allowed to adhere overnight. One well was treated with 10 µL of MCAA+ serum (1:200 
dilution) and the other well was treated with 10 µL IgG-cleared MCAA+ serum. After 2h, a 
nuclear extraction (Signosis, Santa Clara, CA) was performed according to the 
manufacturer’s protocol and samples were stored at 4°C. To screen the nuclear extracts for 
48 different transcription factors, TF Activation Profiling Plate Array I (Signosis) was 
utilized and performed according to the provided protocol. Briefly, nuclear extracts were 
mixed with biotin-labeled probes for the consensus sequences of specific transcription factor 
binding sites. Bound probes were then separated using a spin column. The bound probes 
were separated from the transcription factor complex and analyzed on the hybridization 
plate, which is coated with complementary sequences of the probes. The plate was then 
developed, with luminescence detected and quantified on the microtiter plate reader.
Transcription factor ELISA
To confirm activation (nuclear translocation) of C/EBP-beta and HIF-1α, a sandwich ELISA 
was performed. MeT-5A cells were seeded to confluency in six well plates and allowed to 
adhere overnight. Three wells were treated with 10 µL of pooled MCAA+ serum (1:200 
dilution), three wells were treated with 10 µL of pooled MCAA+ serum cleared of IgG, three 
wells were treated with 1 µM hydrocortisone to induce C/EBP-beta as a positive control 
(Roos and Nord 2012), and three wells were treated with 26 µM N-acetyl-Leu-Leu-
norleucinal (ALLN, Sigma Aldrich, St. Louis MO), a calpain protease inhibitor that has 
been reported to block C/EBP activation (Tang and Lane 2000), to act as a negative control. 
Three wells were treated with 50 µM cobalt chloride (Sigma) to induce HIF-1α as a positive 
control (Piret et al. 2002), and three wells were treated with 20 µM HIF-1α Inhibitor (Santa 
Cruz Biotechnology, Dallas TX) to act as a negative control. After 2h, a nuclear extraction 
was performed as before. Wells of a high binding 96 well plate were coated with 150 ng of 
C/EBP-beta rabbit polyclonal IgG (Santa Cruz) or HIF-1α rabbit polyclonal IgG (ABCAM, 
Cambridge, United Kingdom) per well for 2h. Wells were washed three times for four 
minutes with PBS/Tween-0.05%. Wells were blocked with 5% milk/PBS for 2h. Nuclear 
extracts from each of the wells of the 6-well plates (n=3 in each treatment group) were 
diluted 1:2, and 40µL of the extract was added to 3 replicate wells each, and incubated for 
2h. Wells were washed and blocked as before. 150 ng of C/EBP-beta mouse monoclonal IgG 
(Santa Cruz) or HIF-1α mouse monoclonal IgG (ABCAM) in PBS with 3% BSA were 
added to each well and incubated for 2h. Wells were washed and blocked as before. HRP-
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conjugated goat anti-mouse IgG (Jackson ImmunoResearch) was applied at a dilution of 
1:1000 in 3% BSA/PBS and incubated for 1 hour. Wells were washed as before. 100 µL of 
TMB substrate (Thermo Scientific) was added to each well and reaction was stopped with 
50 µL of HCl per well. Plates were analyzed at 450 nm on a microtiter plate reader. Non-
specific secondary antibody binding was corrected for on a plate-to-plate basis by 
subtracting the mean optical density (OD) for the secondary antibody-only control wells 
from the mean OD of each sample.
Collagen Assay with blocked HIF-1α and CEBP-beta
MeT-5A cells were seeded to confluency in a 96-well plate. For each of the following 
treatments, three wells were treated with either 2 µL of PBS to act as a negative control, 2 
µL of pooled MCAA+ serum (1:50 dilution), 2 µL of pooled MCAA+ serum cleared of IgG 
(Cleared), 26 µM ALLN plus 2 µL of MCAA+ serum, 20 µM HIF-1α inhibitor plus 2 µL of 
MCAA+ serum. The plate was incubated for three days to allow for collagen deposition. 
Final concentration of diluents in the media were 1% ethanol for ALLN and 0.1% DMSO 
for HIF-1 α inhibitor. At these concentrations, neither of the diluents alone showed any 
toxicity to the cells, nor affected collagen production relative to either untreated cells (in the 
absence of MCAA+ serum, P=0.22 for ethanol, 0.89 for DMSO) or MCAA-treated cells (in 
the presence of MCAA+ serum, P=0.45 for ethanol, 0.16 for DMSO) (Data not shown). 
Cells were then blocked with 5% milk in PBS, and then primary antibody rabbit anti-
collagen type 1 (ABCAM) was added at a 1:100 dilution with 3%BSA/PBS. After rinsing 
wells with PBS-Tween (0.05%), the wells were blocked as before. The secondary antibody 
used was HRP-conjugated goat anti-rabbit IgG (ABCAM) diluted 1:1000 with 3%BSA/
PBS. Excess antibody was removed and plates developed using TMB reagent (Thermo 
Scientific), and stopped by 30 µL 1M HCl. Plates were read at 450 nm on a microtiter plate 
reader.
RT2 Profiler qPCR Array
Two T75 flasks were each seeded with 10 million MeT-5A cells, which were allowed to 
settle for 1 hour. One flask was treated with 20 µL of MCAA+ serum and the other flask was 
treated with 20 µL of cleared MCAA+ serum, and the flasks were incubated overnight. An 
RNA spin extraction was performed using RNeasy Mini Kit (SABiosciences, Frederick, 
MD) according to the manufacturer's protocol. RNA quantity and quality was determined by 
the ISU Molecular Research Core Facility using a ND-100 spectrophotometer (NanoDrop, 
Wilmington, DE) and a Fragment Analyzer (Advanced Analytical, Ankeny, IA). Relative 
mRNAs known to be related to fibrosis were quantified using a RT2 Profiler PCR Array for 
Human Fibrosis (Qiagen, Valencia, CA) according to the manufacturer’s instructions. This 
kit allowed for the screening of 83 genes (Table 1) associated with deposition, remodeling, 
and regulation of the extracellular matrix. According to the manufacturer, the assay has high 
(>85%) sensitivity with as little as 5 ng of mRNA from the extraction as long as there is no 
DNA contamination. In this experiment, NanoDrop analysis indicated highly pure RNA with 
negligible DNA.
Each well contained the appropriate primer for the individual gene of interest for that well. 
Real time quantitative PCR allowed for the simultaneous detection and amplification of 
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mRNAs. By observing which wells crossed the threshold cycle earlier in the procedure, the 
relative amounts specific mRNAs was determined. Plates were analyzed using a Bio-Rad 
CFX96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA). The threshold cycle 
was calculated and adjusted according to the manufacturer’s provided equation. 
Fluorescence data was exported to the Qiagen data analysis software where housekeeping 
genes and genomic DNA controls were analyzed to confirm validity of the protocol. The 
fluorescence data of the 83 wells were then analyzed using the same software to compare 
which treatment type contained relatively more mRNA for each appropriate gene. Kit 
instructions state that a difference in threshold cycles of 1 suggest a true up-or down-
regulation to due the sensitivity of the assay, and are reportable.
Statistical analysis
Two-tailed, unpaired t-tests and one-way ANOVA (with Bonferroni post-hoc) tests were 
performed, using StatPlus (StatPlus Software, Walnut, CA). Statistical significance was 
defined as P < 0.05. Data are graphed with error bars indicating standard error of the mean 
(SEM). Graphs are representative of at least two experimental repetitions.
Results
Confirmation of the presence of MCAA in serum from LA-exposed subjects
We hypothesized that exposing human cells to serum containing MCAA would cause 
increased activation of specific transcription factors responsible for regulation of fibrosis. In 
order to test the hypothesis, confirmation of the presence of MCAA in the human serum 
samples was required. The results of the MCAA cell binding assay (Figure 1) showed that 
clearing the IgG from the serum pooled from subjects already shown to be MCAA+ (Serve 
et al. 2013) reduced binding to a minimal level. This allowed us to use the pooled cleared 
serum as a MCAA-negative control in the subsequent experiments.
Screening of transcription factors
To determine which transcription factors were activated due to the presence of MCAA, we 
used a transcription factor profiling array that tested 48 different transcription factors. The 
nuclear extraction allowed us to observe only activated transcription factors that translocated 
to the nucleus. The kit specifies that readings between two samples must be over 2 fold 
(increase or decrease) to be significant. Treatment of the human mesothelial cells with serum 
containing MCAA resulted in differential activation greater than two-fold in 11 of the 48 
examined transcription factors, compared to cells treated with serum cleared of MCAA. A 
representative set of the tested transcription factors are shown in Figure 2, where values 
represent the luminescence of hybridized sequences, indicating the relative amount of 
transcription factor in the nucleus. Of those 11 activated transcription factors, 9 have known 
binding sites to the COL1a1 promoter according to SABiosciences’ DECODE database 
(Table 2). Based on these results, we narrowed our investigation to C/EBP-beta and hypoxia 
inducible factor 1alpha, because their activation was increased more than three-fold, and the 
literature indicates that they have an established association with the extracellular matrix 
(Ghosh 2002).
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Nuclear extract ELISA for activated transcription factors
Following the screening assay, we used sandwich ELISA tests to confirm activation of C/
EBP-beta and HIF-1α after exposure to MCAA serum. We were able to confirm the nuclear 
translocation of both C/EBP-beta and HIF-1α by performing the ELISA tests using nuclear 
extracts of human mesothelial cells to quantify the amount of active transcription factor. 
Human mesothelial cells treated with MCAA serum had significantly (N=3, p < 0.05) more 
active C/EBP-beta and HIF-1α than cells treated with cleared serum (Figure 3 and Figure 4). 
For C/EBP-beta (Figure 3), treatment with ALLN, a selective inhibitor of C/EBP (Tang and 
Lane 2000), significantly reduced C/EBP activation relative to MCAA+ serum, while 
treatment with hydrocortisone increased active C/EBP. For HIF-1α (Figure 4), treatment 
with PBS (negative control) or cleared serum showed similar levels, while both MCAA+ 
serum and cobalt chloride (HIF-1 inducer (Piret et al. 2002)) significantly increased 
activated HIF-1α compared to the controls.
Blocking of collagen deposition
While C/EBP-beta and HIF-1α already have an established connection to the deposition, 
remodeling, and regulation of the extracellular matrix in the literature, it was not known 
whether they would be involved in autoantibody-induced collagen deposition. A firm 
connection between these transcription factors and the increase in collagen deposition 
induced by autoantibodies observed in vitro by Serve et al. (Serve et al. 2013) was needed. 
Blocking the activity of these transcription factors, and then quantifying the collagen 
deposited, tested the hypothesis that they play a key role in this novel mechanism for 
collagen deposition. As expected, the cells that received pooled MCAA+ serum produced 
significantly more collagen than those cells that received pooled serum cleared of IgG. 
Collagen levels were significantly reduced (p < 0.05) from the MCAA-induced levels when 
either C/EBP-beta or HIF activation was blocked with either ALLN (for C/EBP-beta) or 
HIF-1α Inhibitor (Figure 5). However, they did not return to the levels of the negative 
control nor cleared serum.
Gene expression analysis
Analysis of mRNA induced by MCAA exposure was performed to further understand the 
molecular mechanism of this novel pathway of autoantibody-induced collagen deposition. 
Of the 83 genes associated with fibrosis that were analyzed, 56 were detected, 22 of which 
had differences in threshold cycles greater than 1 between treatment groups, and 8 of those 
had differences of 2 or greater (Table 3). Increases in transcription factor mRNA 
corresponded with the transcription factor profile that showed increases for MYC, SP1, and 
STAT1 and structural proteins (integrins), but these increases were quite small (less than 2 
fold). More than 2-fold differences were seen for C/EBP-beta, LOX, PDGFA, TGFBR2, 
TIMP1, and STAT6 among the MCAA treated cells compared to the cells that received 
cleared serum (Table 3, bolded). The mRNAs for matrix metalloproteinases including 
MMP1, MMP14, MMP2, and MMP9 were all slightly decreased while mRNAs for 
metalloproteinase inhibitors such as TIMP1 and TIMP2 were increased, with MCAA 
treatment.
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Our findings support the existence of a novel intracellular mechanism by which mesothelial 
cell autoantibodies induce collagen matrix deposition. Based on these data, it is clear that 
MCAA from LA-exposed subjects induce nuclear translocation of C/EBP-beta and HIF-1α. 
Furthermore, the data indicate those transcription factors play a key role in the increased 
collagen deposition in vitro, and therefore may be associated with LA-induced pleural 
fibrosis. Both C/EBP-beta and HIF-1α have known binding sites in promoters of genes 
responsible for regulation, remodeling, and deposition of collagen (Ghosh 2002). C/EBP-
beta has been shown to act on the COL1A1 and COL1A2 promoters, for which the genes 
code for the fundamental precursor fibers of collagen (Ghosh et al. 2006). C/EBP-beta also 
acts on other transcription factors with known involvement to the regulation of the 
extracellular matrix including Sp1 (Lee et al. 1997). While the data suggest that C/EBP-beta 
plays a role in a significant proportion of the increased collagen deposition (Figure 5), there 
are other possible factors at play. The calpain-1 inhibitor, ALLN, used to block the activity 
of C/EBP-beta, widely inhibits cellular cysteine proteases, which may or may not affect the 
collagen output of these cells through other pathways. Hypoxia inducible factor is 
commonly induced by hypoxic conditions, such as those found in a mass of cancerous cells, 
where HIF is believed to play an important role in activating genes for angiogenesis and 
extracellular matrix deposition (Ghosh 2002, Wong et al. 2011). HIF triggers expression of 
the LOX gene, which codes for the lysyl oxidase protein. Lysyl oxidase is responsible for 
crosslinking between collagen and elastin in the extracellular matrix (Wong et al. 2011). Up-
regulated expression of this specific remodeling gene might be expected during fibrosis; an 
increase in LOX mRNA was observed after treatment with MCAA (Table 3). These data 
show that HIF binding activity may be responsible for a portion of the overall increased 
collagen deposition (Figure 5). These data also suggest HIF can be activated by a different 
signaling pathway, unrelated to overt hypoxic conditions. Our findings reinforce the 
observation made by Serve et al (Serve et al. 2013) that cells exposed to MCAA in vitro 
produce more collagen than cells that receive only cleared serum, and that the collagen is 
produced in the absence of epithelial/mesenchymal transition (EMT). Moreover, we did not 
observe any significant changes in Smads, NF-kB, nor p53 activation (Table 2), which are 
traditionally associated with fibrosis (Serve et al. 2013). Taken together, these data suggest 
that autoantibody mediated fibrosis acts via a different intracellular pathway than cytokine 
mediated fibrosis.
The collagen assay specifically quantifies collagen matrix produced by the cells; however, 
fibrosis involves more than just the production of collagen. The gene expression data 
confirms that other genes for the structural subunits of the extracellular matrix such as 
integrins are also being transcribed. Integrins are important as they function to attach the 
extracellular matrix to the cytoskeleton of the cells. The gene expression data also show that 
the transcription factors that were activated correlated with an increase in respective 
mRNAs. While an increase in transcription factor mRNA does not confirm the presence of 
activated transcription factors, the correlation is worth pointing out because it sets the stage 
for continued responsiveness of these pathways. Beyond that, these data show a uniform 
decrease in mRNAs for all the matrix metalloproteinases studied. This decrease is 
Gilmer et al. Page 8













noteworthy because the MMPs are responsible for breaking down the ECM (Visse and 
Nagase 2003), so if this reduced transcription correlates with low protein levels, this could 
contribute to reduced matrix degradation and thus the increase in the ECM observed. 
Contrary to what we expected, Serve et al observed an increase in presence and activity of 
MMP-8 and -9 when using a zymogen assay, which measures the actual proteins (Serve et 
al. 2013). The data also show an increase in the tissue specific metalloproteinase inhibitor 
(TIMP) mRNAs, which suggests another possible source of increased extracellular matrix as 
these proteins are responsible for inhibiting MMPs (Visse and Nagase 2003). Further studies 
need to be conducted to assess the amount and activity of these MMPs, TIMPs, and other 
ECM feedback proteins to better understand the dysregulation observed. Future studies also 
need to fully characterize the protein amounts and activity levels of the proteins in this 
pathway in order to understand MCAA-induced fibrosis.
Other autoimmune diseases have also been associated with fibrosis. Autoimmune hepatitis 
results in fibrosis of the liver (Bataller and Brenner 2005). While the exact mechanism 
behind this disease is not completely understood, the link between autoantibodies and 
fibrosis is strong (Bataller and Brenner 2005). Scleroderma is a systemic autoimmune 
disease involving fibrosis of connective tissue in various areas of the human body (Gabrielli 
et al. 2009). The severity of the disease correlates with presence of autoantibodies, but their 
specific role remains uncertain (Ihn et al. 2000). There is also a correlation between 
endothelial cell autoantibodies and pulmonary fibrosis (Ihn et al. 2000). Presence of 
autoantibodies is often used to aid in the diagnosis of a disease, but more consideration 
needs to be taken into the effect of these autoantibodies in the ultimate pathological 
outcome. This study connects the presence of autoantibodies to activation of specific 
transcription factors associated with fibrosis. Since LA induces these autoantibodies, this 
mechanism represents a critical candidate pathway contributing to the pleural fibrosis 
observed in the Libby patients.
Further studies need to be conducted to completely characterize this novel mechanism by 
which MCAA induce collagen deposition. This study only observed 48 transcription factors 
and 83 mRNAs. It is likely that the process of autoantibody-induced fibrosis involves more 
molecules than the ones investigated. Additional targets of these MCAA need to be 
identified in order to better understand the signal transduction pathway leading up to 
transcription factor activation. Determining whether MCAA induced collagen deposition is 
indeed connected with fibrosis in the pleural cavity will help to determine the connection to 
LA disease. The insight gained from this study reinforces the autoimmune component 
behind the disease, and helps illuminate new potential treatment approaches for this 
devastating disease.
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Binding ELISA demonstrating the autoantibody binding to Met5A mesothelial cells due to 
the presence of MCAA in serum from human patients exposed to LA fibers. Sera were 
pooled from MCAA positive samples (MCAA+) and MCAA-positive samples cleared of all 
IgG (Cleared). Human mesothelial cells were plated in 96-well plates and then stained for 
MCAA binding using the pooled serum as the primary antibody and anti-human IgG - HRP 
for the secondary antibody. N= 3 samples per treatment group. Data are mean absorbance at 
450 nm. *=p<0.001 by 2-tailed t-test.
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Transcription factor (TF) profile showing difference in amount of active transcription factor 
based on treatment. A nuclear extraction was performed and assessed for relative levels of 
activation by detection of presence of TF in the nucleus. Luminescence was detected when 
TF-bound sequences hybridized with complimentary sequences on the plate. Hatched bars 
indicate treatment of human mesothelial cells with pooled MCAA+ serum cleared of IgG. 
Black bars indicate treatment of human mesothelial cells with pooled MCAA+ serum.
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MCAA-induced increase in amount of active C/EBP-beta in nuclear extracts. Human 
mesothelial cells were plated in 6-well plates and then exposed to treatments (3 wells per 
treatment) for two hours before nuclear extraction. Negative control wells were treated with 
ALLN. Positive control wells were treated with hydrocortisone to induce C/EBP-beta. The 
nuclear extract of each well was then tested for the presence of C/EBP-beta by sandwich 
ELISA. N= 3 separate extracts per treatment group. a=p<0.05 compared to MCAA+; 
b=p<0.05 compared to Cleared, by both 2-tailed t-test and by 1-way ANOVA with 
Bonferroni post-hoc testing.
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MCAA-induced increase in amount of active hypoxia inducible factor in nuclear extracts, or 
positive control CoCl2. Human mesothelial cells were plated in 6-well plates and then 
exposed to treatments (3 wells per treatment) for two hours before nuclear extraction. The 
nuclear extract from each well was then tested for the presence of HIF-1α by sandwich 
ELISA. N= 3 separate extracts per treatment group. a=p<0.05 compared to MCAA+; 
b=p<0.05 compared to Cleared, by both 2-tailed t-test and by 1-way ANOVA with 
Bonferroni post-hoc testing.
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In vitro (cell based, Met5A cells) collagen assays demonstrating the reduced collagen 
deposition after blocking transcription factor activity, using ALLN (for C/EBP, left side of 
graph) or HIF 1-alpha inhibitor (right side). Cells exposed to MCAA produced significantly 
more collagen than cells that received cleared serum for both experiments (right and left side 
of graph). Cells treated with inhibitors had the respective transcription factor’s activity 
inhibited. a=p<0.05 compared to PBS control; b=p<0.05 compared to MCAA+, by 2-tailed 
t-test and 1-way ANOVA with Bonferroni post-hoc testing. Other P values for comparisons 
in this graph are in this table:
P-Value HIF C/EBP
MCAA vs Blocked 0.029 0.041
Cleared vs Blocked 0.002 0.021
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Blocked vs Blocked 0.027 0.027
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Table 1
All 83 fibrosis-associated genes analyzed in the RT qPCR gene expression experiment (RT2 Profiler PCR 
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Table 2
Table showing results of the TF array, indicating the amount of increase in active transcription factor in cells 
that were exposed to MCAA serum relative to cells exposed to cleared serum. The 9 bolded pathways have a 






AP1 1.664 NF-1 6.346
AP2 1.206 NFAT 1.318
AR 1.934 NF-E2 0.361
ATF2 1.883 NFkB 1.558
Brn-3 0.810 OCT. 4 1.715
C\EBP 16.166 p53 1.372
CAR 1.500 Pax-5 3.545
CBF 0.976 Pbx1 1.714
CDP 1.763 Pit 0.471
CREB 0.839 PPAR 1.101
E2F-1 1.981 PXR 2.695
EGR 1.463 SMAD 0.602
ER 1.610 Sp1 0.880
Ets 1.642 SRF 1.356
FAST-1 1.052 SATB1 11.450
GAS/ISRE 1.509 Stat1 1.029
GATA 5.866 Stat3 1.443
GR/PR 2.424 Stat4 0.746
HIF 9.016 Stat5 2.231
HNF4 0.404 Stat6 0.864
IRF 0.943 TCF/LEF 1.190
MEF2 1.125 TR 0.520
Myb 1.923 YY1 1.148
Myc-Max 2.602 TFIID 7.440
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Table 3
Table displaying relative differences in threshold cycles of genes studied in the RT2 Profiler Array for Human 
Fibrosis (Qiagen). The gene symbol corresponds to the abbreviation for the gene product. The difference was 
calculated by subtracting the threshold cycle values for MCAA+ serum treatment from those of the cleared 
serum treatment. Positive difference values indicate there was more starting mRNA in the MCAA+ samples 
than the cleared samples, while negative difference values indicate less starting mRNA in the MCAA+ 



















































Inhal Toxicol. Author manuscript; available in PMC 2018 January 01.
